Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Abbott
Dow
Johnson and Johnson

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Lithuania Drug Patents

See Plans and Pricing

« Back to Dashboard

Drug Patents in Lithuania and US Equivalents

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
Patent Number Estimated Expiration Equivalent US Patent US Expiry Date Generic Name US Applicant US Tradename
1765292   Start Trial 10004729 Dec 10, 2030 oxycodone Collegium Pharm Inc XTAMPZA ER
2451445   Start Trial 10004743 Jul 5, 2030 afatinib dimaleate Boehringer Ingelheim GILOTRIF
2727918   Start Trial 10005761 Aug 27, 2030 encorafenib Array Biopharma Inc BRAFTOVI
2727918   Start Trial 10005761 Aug 27, 2030 binimetinib Array Biopharma Inc MEKTOVI
PA2019005   Start Trial 10005761 Aug 27, 2030 encorafenib Array Biopharma Inc BRAFTOVI
>Patent Number >Estimated Expiration >Equivalent US Patent >US Expiry Date >Generic Name >US Applicant >US Tradename

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Abbott
McKinsey
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.